CD8A and neoplasm: The neoantigens are also recognized by CD8+ T cells, via the interaction between the MHC-I tumor-associated antigens and T-cell receptor (TCR), and are associated with a more favorable prognosis, while dendritic cells (DCs), which are part of TME, facilitate the identification of the neoantigen CD8+ T cells.